Cargando…

PDCD10 Gene Mutations in Multiple Cerebral Cavernous Malformations

Cerebral cavernous malformations (CCMs) are vascular abnormalities that may cause seizures, intracerebral haemorrhages, and focal neurological deficits. Familial form shows an autosomal dominant pattern of inheritance with incomplete penetrance and variable clinical expression. Three genes have been...

Descripción completa

Detalles Bibliográficos
Autores principales: Cigoli, Maria Sole, Avemaria, Francesca, De Benedetti, Stefano, Gesu, Giovanni P., Accorsi, Lucio Giordano, Parmigiani, Stefano, Corona, Maria Franca, Capra, Valeria, Mosca, Andrea, Giovannini, Simona, Notturno, Francesca, Ciccocioppo, Fausta, Volpi, Lilia, Estienne, Margherita, De Michele, Giuseppe, Antenora, Antonella, Bilo, Leda, Tavoni, Antonietta, Zamponi, Nelia, Alfei, Enrico, Baranello, Giovanni, Riva, Daria, Penco, Silvana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4212902/
https://www.ncbi.nlm.nih.gov/pubmed/25354366
http://dx.doi.org/10.1371/journal.pone.0110438
Descripción
Sumario:Cerebral cavernous malformations (CCMs) are vascular abnormalities that may cause seizures, intracerebral haemorrhages, and focal neurological deficits. Familial form shows an autosomal dominant pattern of inheritance with incomplete penetrance and variable clinical expression. Three genes have been identified causing familial CCM: KRIT1/CCM1, MGC4607/CCM2, and PDCD10/CCM3. Aim of this study is to report additional PDCD10/CCM3 families poorly described so far which account for 10-15% of hereditary cerebral cavernous malformations. Our group investigated 87 consecutive Italian affected individuals (i.e. positive Magnetic Resonance Imaging) with multiple/familial CCM through direct sequencing and Multiplex Ligation-Dependent Probe Amplification (MLPA) analysis. We identified mutations in over 97.7% of cases, and PDCD10/CCM3 accounts for 13.1%. PDCD10/CCM3 molecular screening revealed four already known mutations and four novel ones. The mutated patients show an earlier onset of clinical manifestations as compared to CCM1/CCM2 mutated patients. The study of further families carrying mutations in PDCD10/CCM3 may help define a possible correlation between genotype and phenotype; an accurate clinical follow up of the subjects would help define more precisely whether mutations in PDCD10/CCM3 lead to a characteristic phenotype.